AMahajanMD Profile Banner
Abhimanyu Mahajan Profile
Abhimanyu Mahajan

@AMahajanMD

Followers
6K
Following
18K
Media
1K
Statuses
7K

Movement disorders neurologist at the University of Cincinnati. Views are my own and never medical advice.

Joined July 2013
Don't wanna be here? Send us removal request.
@AMahajanMD
Abhimanyu Mahajan
3 hours
Time change: . @AANmember Section Spotlight: Job Search and Early Career in Academic Movement Disorders. When: 9/17/25 at 6 pm EST. Featured speaker: .Dr. Kelly Mills @kmillsy .Director, Movement Disorders Division @HopkinsMedicine . Registration:
Tweet media one
0
2
3
@AMahajanMD
Abhimanyu Mahajan
20 hours
AAN Movement Disorders Section Spotlight: Mid-career Neurologists in Academic Medicine. When: 11/6/25, 6 pm EST. Target audience: All early and mid career neurologists, Division and department leadership . Featured speaker: Prof. @MichaelOkun. Register:
Tweet media one
0
3
8
@AMahajanMD
Abhimanyu Mahajan
4 days
RT @UCMovDis: With nearly 400 PWPs, families and friends at the Sunflower Rev It Up for Parkinson’s Symposium in Cincinnati. .
0
3
0
@AMahajanMD
Abhimanyu Mahajan
6 days
Thank you to everyone who has responded so far. As a reminder, this survey has been deemed IRB-exempt and is completely de-identified. Please help spread the word to maximize response and generalizability. Link:
@AMahajanMD
Abhimanyu Mahajan
10 days
If you are:. 1. A movement disorders trained physician.2.Practicing in an academic center .in the US. Please take 5-10 minutes to fill out this survey to identify factors important for retention and recruitment of movement disorders neurologists.
Tweet media one
0
1
1
@AMahajanMD
Abhimanyu Mahajan
7 days
RT @EnriqueZenitram: What if adaptive DBS in Parkinson’s didn’t just listen to one brain signal, but knew when you were moving?. We dropped….
Tweet card summary image
movementdisorders.onlinelibrary.wiley.com
Click on the article title to read more.
0
5
0
@AMahajanMD
Abhimanyu Mahajan
10 days
If you are:. 1. A movement disorders trained physician.2.Practicing in an academic center .in the US. Please take 5-10 minutes to fill out this survey to identify factors important for retention and recruitment of movement disorders neurologists.
Tweet media one
1
6
10
@AMahajanMD
Abhimanyu Mahajan
10 days
RT @MichaelOkun: Do you know the 2025 updates in diagnosis and treatment of paroxysmal movement disorders? What are the causes of the sudde….
0
32
0
@AMahajanMD
Abhimanyu Mahajan
11 days
RT @DGlaucomflecken: Doctors want you to get better
Tweet media one
0
266
0
@AMahajanMD
Abhimanyu Mahajan
14 days
We welcome back Dr. Miguel Situ to @UCincyMedicine for Neurology Grand Rounds. The title of his presentation: Functional Movement Disorders and the spirit of modern neurology.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
9
@AMahajanMD
Abhimanyu Mahajan
16 days
RT @movedisorder: What began as a bold idea—naming a clinic "Movement Disorders"—sparked a global revolution in neurology. Join us at the….
0
8
0
@AMahajanMD
Abhimanyu Mahajan
19 days
The clinically and conceptually fascinating topic of Paroxysmal Movement Disorders. Honored to contribute to the 2025 Movement disorders issue for @ContinuumAAN . Thank you for the invitation @MichaelOkun @LyellJ . Link:
Tweet media one
3
16
83
@AMahajanMD
Abhimanyu Mahajan
23 days
RT @ClinicalNeuroph: [Brain mapping] Guggisberg et al.: "This chapter reviews recent breakthroughs in neurophysiological brain mapping, foc….
0
5
0
@AMahajanMD
Abhimanyu Mahajan
24 days
RT @MichaelOkun: The basal ganglia helps you with what to do and what not to do. The cerebellum helps you with the timing of what needs to….
0
24
0
@AMahajanMD
Abhimanyu Mahajan
26 days
Can’t wait to read the entire @ContinuumAAN issue on Movement disorders. Debuts in a week!.
@ContinuumAAN
Continuum: Lifelong Learning in Neurology
26 days
The next issue on Movement Disorders, guest edited by Dr. Michael Okun, publishes on August 1! @MichaelOkun @AlanCarson15 @AMahajanMD @DrRawlsMoveMD @KatiePMooreMD @ludyshihmd @jonstoneneuro @LyellJ @AANMember.#Neurology #MedEd #NeuroTwitter
Tweet media one
0
1
31
@AMahajanMD
Abhimanyu Mahajan
1 month
From the @SchmahmannLab . Diagnostic success rate was 90.0% (27/30) in those with onset > 45 years. Cerebellar atrophy seen in 97.1% (34/35), mostly in vermis/paravermis. Clinically meaningful improvement with 4-AP in 71.0% (22/31) of patients.
Tweet media one
2
1
16
@AMahajanMD
Abhimanyu Mahajan
1 month
RT @Nature: Researchers have been sneaking secret messages into their papers in an effort to trick AI tools into giving them a positive pee….
0
197
0
@AMahajanMD
Abhimanyu Mahajan
1 month
“. our review revealed that from 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. Even more stunningly, 87% of those academic breakthroughs came from American institutions.”. via @statnews.
Tweet card summary image
statnews.com
From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.
0
0
4
@AMahajanMD
Abhimanyu Mahajan
1 month
Science is incredible. Huge implications for patients, and the field of recovery and neurorestoration.
@MichaelOkun
Michael Okun
1 month
From robotic to real? We are entering a new era of mind-controlled limbs. Neuroprosthetic limbs are no longer science fiction, they are rapidly transforming into natural extensions of the human body. A remarkable new review by Tian, Kemp and colleagues in Annals of Neurology lays
Tweet media one
0
1
7